{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:15:26Z","timestamp":1791918926100,"version":"4.3.4"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"30","license":[{"start":{"date-parts":[[2013,10,7]],"date-time":"2013-10-07T00:00:00Z","timestamp":1381104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1038\/onc.2013.398","type":"journal-article","created":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T14:38:05Z","timestamp":1381243085000},"page":"4003-4015","source":"Crossref","is-referenced-by-count":87,"title":["Impaired DICER1 function promotes stemness and metastasis in colon cancer"],"prefix":"10.1038","volume":"33","author":[{"given":"M S","family":"Iliou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"da Silva-Diz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F J","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ramalho-Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Heyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Esteller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,7]]},"reference":[{"key":"BFonc2013398_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP . MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215\u2013233.","journal-title":"Cell"},{"key":"BFonc2013398_CR2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V . The functions of animal microRNAs. Nature 2004; 431: 350\u2013355.","journal-title":"Nature"},{"key":"BFonc2013398_CR3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.cell.2009.02.005","volume":"136","author":"A Ventura","year":"2009","unstructured":"Ventura A, Jacks T . MicroRNAs and cancer: short RNAs go a long way. Cell 2009; 136: 586\u2013591.","journal-title":"Cell"},{"key":"BFonc2013398_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature10888","volume":"482","author":"A Lujambio","year":"2012","unstructured":"Lujambio A, Lowe SW . The microcosmos of cancer. Nature 2012; 482: 347\u2013355.","journal-title":"Nature"},{"key":"BFonc2013398_CR5","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834\u2013838.","journal-title":"Nature"},{"key":"BFonc2013398_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM . MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857\u2013866.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2013398_CR7","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1158\/0008-5472.CAN-06-2698","volume":"67","author":"A Gaur","year":"2007","unstructured":"Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 2007; 67: 2456\u20132468.","journal-title":"Cancer Res"},{"key":"BFonc2013398_CR8","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1101\/gad.1444406","volume":"20","author":"JM Thomson","year":"2006","unstructured":"Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, Hammond SM . Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 2006; 20: 2202\u20132207.","journal-title":"Genes Dev"},{"key":"BFonc2013398_CR9","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.4161\/cc.5.19.3340","volume":"5","author":"Y Saito","year":"2006","unstructured":"Saito Y, Jones PA . Epigenetic activation of tumor suppressor microRNAs in human cancer cells. Cell Cycle 2006; 5: 2220\u20132222.","journal-title":"Cell Cycle"},{"key":"BFonc2013398_CR10","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/onc.2011.354","volume":"31","author":"P Lopez-Serra","year":"2012","unstructured":"Lopez-Serra P, Esteller M . DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 2012; 31: 1609\u20131622.","journal-title":"Oncogene"},{"key":"BFonc2013398_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/ng.2007.30","volume":"40","author":"TC Chang","year":"2008","unstructured":"Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008; 40: 43\u201350.","journal-title":"Nat Genet"},{"key":"BFonc2013398_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/ng.317","volume":"41","author":"SA Melo","year":"2009","unstructured":"Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 2009; 41: 365\u2013370.","journal-title":"Nat Genet"},{"key":"BFonc2013398_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ccr.2010.09.007","volume":"18","author":"SA Melo","year":"2010","unstructured":"Melo SA, Moutinho C, Ropero S, Calin GA, Rossi S, Spizzo R et al. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 2010; 18: 303\u2013315.","journal-title":"Cancer Cell"},{"key":"BFonc2013398_CR14","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1101\/gad.1848209","volume":"23","author":"MS Kumar","year":"2009","unstructured":"Kumar MS, Pester RE, Chen CY, Lane K, Chin C, Lu J et al. Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev 2009; 23: 2700\u20132704.","journal-title":"Genes Dev"},{"key":"BFonc2013398_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1056\/NEJMoa1102903","volume":"366","author":"A Heravi-Moussavi","year":"2012","unstructured":"Heravi-Moussavi A, Anglesio MS, Cheng SW, Senz J, Yang W, Prentice L et al. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med 2012; 366: 234\u2013242.","journal-title":"N Engl J Med"},{"key":"BFonc2013398_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1349-7006.2005.00015.x","volume":"96","author":"Y Karube","year":"2005","unstructured":"Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, Yanagisawa K et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 2005; 96: 111\u2013115.","journal-title":"Cancer Sci"},{"key":"BFonc2013398_CR17","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1056\/NEJMoa0803785","volume":"359","author":"WM Merritt","year":"2008","unstructured":"Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R et al. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 2008; 359: 2641\u20132650.","journal-title":"N Engl J Med"},{"key":"BFonc2013398_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10549-012-2169-3","volume":"135","author":"SM Khoshnaw","year":"2012","unstructured":"Khoshnaw SM, Rakha EA, Abdel-Fatah TM, Nolan CC, Hodi Z, Macmillan DR et al. Loss of Dicer expression is associated with breast cancer progression and recurrence. Breast Cancer Res Treat 2012; 135: 403\u2013413.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc2013398_CR19","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.prp.2012.05.001","volume":"208","author":"GS Shu","year":"2012","unstructured":"Shu GS, Yang ZL, Liu DC . Immunohistochemical study of Dicer and Drosha expression in the benign and malignant lesions of gallbladder and their clinicopathological significances. Pathol Res Pract 2012; 208: 392\u2013397.","journal-title":"Pathol Res Pract"},{"key":"BFonc2013398_CR20","first-page":"695","volume":"5","author":"D Wu","year":"2012","unstructured":"Wu D, Tao J, Xu B, Li P, Lu Q, Zhang W . Downregulation of Dicer, a component of the microRNA machinery, in bladder cancer. Mol Med Report 2012; 5: 695\u2013699.","journal-title":"Mol Med Report"},{"key":"BFonc2013398_CR21","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/j.1349-7006.2012.02234.x","volume":"103","author":"DX Zhu","year":"2012","unstructured":"Zhu DX, Fan L, Lu RN, Fang C, Shen WY, Zou ZJ et al. Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia. Cancer Sci 2012; 103: 875\u2013881.","journal-title":"Cancer Sci"},{"key":"BFonc2013398_CR22","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1365-2559.2011.04110.x","volume":"61","author":"A Faggad","year":"2012","unstructured":"Faggad A, Kasajima A, Weichert W, Stenzinger A, Elwali NE, Dietel M et al. Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer. Histopathology 2012; 61: 552\u2013561.","journal-title":"Histopathology"},{"key":"BFonc2013398_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00432-011-1058-1","volume":"138","author":"X Guo","year":"2012","unstructured":"Guo X, Liao Q, Chen P, Li X, Xiong W, Ma J et al. The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma. J Cancer Res Clin Oncol 2012; 138: 49\u201356.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFonc2013398_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/1471-2407-11-345","volume":"11","author":"J Stratmann","year":"2011","unstructured":"Stratmann J, Wang CJ, Gnosa S, Wallin A, Hinselwood D, Sun XF et al. Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients. BMC Cancer 2011; 11: 345.","journal-title":"BMC Cancer"},{"key":"BFonc2013398_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/sj.bjc.6605193","volume":"101","author":"G Grelier","year":"2009","unstructured":"Grelier G, Voirin N, Ay AS, Cox DG, Chabaud S, Treilleux I et al. Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. Br J Cancer 2009; 101: 673\u2013683.","journal-title":"Br J Cancer"},{"key":"BFonc2013398_CR26","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.cell.2010.05.017","volume":"141","author":"G Martello","year":"2010","unstructured":"Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, Dupont S et al. A MicroRNA targeting dicer for metastasis control. Cell 2010; 141: 1195\u20131207.","journal-title":"Cell"},{"key":"BFonc2013398_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/ng1253","volume":"35","author":"E Bernstein","year":"2003","unstructured":"Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ et al. Dicer is essential for mouse development. Nat Genet 2003; 35: 215\u2013217.","journal-title":"Nat Genet"},{"key":"BFonc2013398_CR28","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/ncb1155","volume":"6","author":"T Fukagawa","year":"2004","unstructured":"Fukagawa T, Nogami M, Yoshikawa M, Ikeno M, Okazaki T, Takami Y et al. Dicer is essential for formation of the heterochromatin structure in vertebrate cells. Nat Cell Biol 2004; 6: 784\u2013791.","journal-title":"Nat Cell Biol"},{"key":"BFonc2013398_CR29","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1101\/gad.418707","volume":"21","author":"F Tang","year":"2007","unstructured":"Tang F, Kaneda M, O'Carroll D, Hajkova P, Barton SC, Sun YA et al. Maternal microRNAs are essential for mouse zygotic development. Genes Dev 2007; 21: 644\u2013648.","journal-title":"Genes Dev"},{"key":"BFonc2013398_CR30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nature09781","volume":"469","author":"JE Visvader","year":"2011","unstructured":"Visvader JE . Cells of origin in cancer. Nature 2011; 469: 314\u2013322.","journal-title":"Nature"},{"key":"BFonc2013398_CR31","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1073\/pnas.0511155103","volume":"103","author":"JM Cummins","year":"2006","unstructured":"Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, Sjoblom et al. The colorectal microRNAome. Proc Natl Acad Sci USA 2006; 103: 3687\u20133692.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013398_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature05384","volume":"445","author":"L Ricci-Vitiani","year":"2007","unstructured":"Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111\u2013115.","journal-title":"Nature"},{"key":"BFonc2013398_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature05372","volume":"445","author":"CA O'Brien","year":"2007","unstructured":"O'Brien CA, Pollett A, Gallinger S, Dick JE . A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106\u2013110.","journal-title":"Nature"},{"key":"BFonc2013398_CR34","doi-asserted-by":"publisher","first-page":"13427","DOI":"10.1073\/pnas.0805706105","volume":"105","author":"L Vermeulen","year":"2008","unstructured":"Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, Perez Alea M et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci USA 2008; 105: 13427\u201313432.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013398_CR35","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nature07602","volume":"457","author":"N Barker","year":"2009","unstructured":"Barker N, Ridgway RA, van Es JH . van de Wetering M, Begthel H, van den Born M et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009; 457: 608\u2013611.","journal-title":"Nature"},{"key":"BFonc2013398_CR36","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1002\/stem.1233","volume":"30","author":"K Kemper","year":"2012","unstructured":"Kemper K, Prasetyanti PR, De Lau W, Rodermond H, Clevers H, Medema JP . Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells. Stem Cells 2012; 30: 2378\u20132386.","journal-title":"Stem Cells"},{"key":"BFonc2013398_CR37","doi-asserted-by":"publisher","first-page":"10158","DOI":"10.1073\/pnas.0703478104","volume":"104","author":"P Dalerba","year":"2007","unstructured":"Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007; 104: 10158\u201310163.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013398_CR38","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nm.2284","volume":"17","author":"C Liu","year":"2011","unstructured":"Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 2011; 17: 211\u2013215.","journal-title":"Nat Med"},{"key":"BFonc2013398_CR39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bbrc.2010.10.130","volume":"403","author":"JC Henry","year":"2010","unstructured":"Henry JC, Park JK, Jiang J, Kim JH, Nagorney DM, Roberts LR et al. miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 2010; 403: 120\u2013125.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2013398_CR40","doi-asserted-by":"publisher","first-page":"e2420","DOI":"10.1371\/journal.pone.0002420","volume":"3","author":"CH Wang","year":"2008","unstructured":"Wang CH, Lee DY, Deng Z, Jeyapalan Z, Lee SC, Kahai S et al. MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression. PLoS One 2008; 3: e2420.","journal-title":"PLoS One"},{"key":"BFonc2013398_CR41","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1093\/nar\/gkq1003","volume":"39","author":"Z Jeyapalan","year":"2011","unstructured":"Jeyapalan Z, Deng Z, Shatseva T, Fang L, He C, Yang BB . Expression of CD44 3'-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis. Nucleic Acids Res 2011; 39: 3026\u20133041.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2013398_CR42","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ncb1681","volume":"10","author":"Q Huang","year":"2008","unstructured":"Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 2008; 10: 202\u2013210.","journal-title":"Nat Cell Biol"},{"key":"BFonc2013398_CR43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0002-9440(10)65297-2","volume":"154","author":"VJ Wielenga","year":"1999","unstructured":"Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R et al. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 1999; 154: 515\u2013523.","journal-title":"Am J Pathol"},{"key":"BFonc2013398_CR44","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1126\/science.275.5307.1787","volume":"275","author":"PJ Morin","year":"1997","unstructured":"Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275: 1787\u20131790.","journal-title":"Science"},{"key":"BFonc2013398_CR45","doi-asserted-by":"publisher","first-page":"10330","DOI":"10.1073\/pnas.94.19.10330","volume":"94","author":"M Ilyas","year":"1997","unstructured":"Ilyas M, Tomlinson IP, Rowan A, Pignatelli M, Bodmer WF . Beta-catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci USA 1997; 94: 10330\u201310334.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013398_CR46","first-page":"1130","volume":"58","author":"AB Sparks","year":"1998","unstructured":"Sparks AB, Morin PJ, Vogelstein B, Kinzler KW . Mutational analysis of the APC\/beta-catenin\/Tcf pathway in colorectal cancer. Cancer Res 1998; 58: 1130\u20131134.","journal-title":"Cancer Res"},{"key":"BFonc2013398_CR47","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4161\/cbt.10.3.12548","volume":"10","author":"PS Mongroo","year":"2010","unstructured":"Mongroo PS, Rustgi AK . The role of the miR-200 family in epithelial-mesenchymal transition. Cancer Biol Ther 2010; 10: 219\u2013222.","journal-title":"Cancer Biol Ther"},{"key":"BFonc2013398_CR48","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/nm.1880","volume":"14","author":"D Bonci","year":"2008","unstructured":"Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 2008; 14: 1271\u20131277.","journal-title":"Nat Med"},{"key":"BFonc2013398_CR49","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/bcr1867","volume":"10","author":"M Negrini","year":"2008","unstructured":"Negrini M, Calin GA . Breast cancer metastasis: a microRNA story. Breast Cancer Res 2008; 10: 203.","journal-title":"Breast Cancer Res"},{"key":"BFonc2013398_CR50","doi-asserted-by":"publisher","first-page":"e26257","DOI":"10.1371\/journal.pone.0026257","volume":"6","author":"R Anton","year":"2011","unstructured":"Anton R, Chatterjee SS, Simundza J, Cowin P, Dasgupta R . A systematic screen for micro-RNAs regulating the canonical Wnt pathway. PLoS One 2011; 6: e26257.","journal-title":"PLoS One"},{"key":"BFonc2013398_CR51","first-page":"ra71","volume":"4","author":"NH Kim","year":"2011","unstructured":"Kim NH, Kim HS, Kim NG, Lee I, Choi HS, Li XY et al. p53 and MicroRNA-34 Are Suppressors of Canonical Wnt Signaling. Sci Signal 2011; 4: ra71.","journal-title":"Sci Signal"},{"key":"BFonc2013398_CR52","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/nature09459","volume":"467","author":"X Su","year":"2010","unstructured":"Su X, Chakravarti D, Cho MS, Liu L, Gi YJ, Lin YL et al. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 2010; 467: 986\u2013990.","journal-title":"Nature"},{"key":"BFonc2013398_CR53","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/carcin\/bgs329","volume":"34","author":"Z Luo","year":"2012","unstructured":"Luo Z, Dai Y, Zhang L, JiangC Li Z, Yang J et al. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. Carcinogenesis 2012; 34: 415\u2013425.","journal-title":"Carcinogenesis"},{"key":"BFonc2013398_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gde.2003.11.007","volume":"14","author":"M Al-Hajj","year":"2004","unstructured":"Al-Hajj M, Becker MW, Wicha M, Weissman I, Clarke MF . Therapeutic implications of cancer stem cells. Curr Opin Genet Dev 2004; 14: 43\u201347.","journal-title":"Curr Opin Genet Dev"},{"key":"BFonc2013398_CR55","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","volume":"1","author":"PC Hermann","year":"2007","unstructured":"Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1: 313\u2013323.","journal-title":"Cell Stem Cell"},{"key":"BFonc2013398_CR56","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou A et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704\u2013715.","journal-title":"Cell"},{"key":"BFonc2013398_CR57","doi-asserted-by":"publisher","first-page":"18115","DOI":"10.1073\/pnas.1006732107","volume":"107","author":"H Liu","year":"2010","unstructured":"Liu H, Patel MR, Prescher JA, Patsialou A, Qian D, Lin J et al. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Natl Acad Sci USA 2010; 107: 18115\u201318120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013398_CR58","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.stem.2010.04.001","volume":"6","author":"R Pang","year":"2010","unstructured":"Pang R, Law WL, Chu AC, Poon JT, Lam CS, Chow AK et al. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 2010; 6: 603\u2013615.","journal-title":"Cell Stem Cell"},{"key":"BFonc2013398_CR59","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ncb1722","volume":"10","author":"PA Gregory","year":"2008","unstructured":"Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593\u2013601.","journal-title":"Nat Cell Biol"},{"key":"BFonc2013398_CR60","doi-asserted-by":"publisher","first-page":"14910","DOI":"10.1074\/jbc.C800074200","volume":"283","author":"M Korpal","year":"2008","unstructured":"Korpal M, Lee ES, Hu G, Kang Y . The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008; 283: 14910\u201314914.","journal-title":"J Biol Chem"},{"key":"BFonc2013398_CR61","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1101\/gad.1640608","volume":"22","author":"SM Park","year":"2008","unstructured":"Park SM, Gaur AB, Lengyel E, Peter ME . The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008; 22: 894\u2013907.","journal-title":"Genes Dev"},{"key":"BFonc2013398_CR62","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nature06487","volume":"451","author":"SF Tavazoie","year":"2008","unstructured":"Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451: 147\u2013152.","journal-title":"Nature"},{"key":"BFonc2013398_CR63","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.canlet.2010.06.004","volume":"298","author":"R Feng","year":"2010","unstructured":"Feng R, Chen X, Yu Y, Su L, Yu B, Li J et al. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 2010; 298: 50\u201363.","journal-title":"Cancer Lett"},{"key":"BFonc2013398_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/1541-7786.MCR-11-0272","volume":"10","author":"S Hamada","year":"2012","unstructured":"Hamada S, Satoh K, Fujibuchi W, Hirota M, Kanno A, Unno J et al. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9. Mol Cancer Res 2012; 10: 3\u201310.","journal-title":"Mol Cancer Res"},{"key":"BFonc2013398_CR65","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/bjc.2012.330","volume":"107","author":"T Sasahira","year":"2012","unstructured":"Sasahira T, Kurihara M, Bhawal UK, Ueda N, Shimomoto T, Yamamoto K et al. Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer 2012; 107: 700\u2013706.","journal-title":"Br J Cancer"},{"key":"BFonc2013398_CR66","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/cdd.2010.167","volume":"18","author":"M Tome","year":"2011","unstructured":"Tome M, Lopez-Romero P, Albo C, Sepulveda JC, Fernandez-Gutierrez B, Dopazo A et al. miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ 2011; 18: 985\u2013995.","journal-title":"Cell Death Differ"},{"key":"BFonc2013398_CR67","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1101\/gad.1974211","volume":"25","author":"KJ Png","year":"2011","unstructured":"Png KJ, Yoshida M, Zhang XH, Shu W, Lee H, Rimner A et al. MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev 2011; 25: 226\u2013231.","journal-title":"Genes Dev"},{"key":"BFonc2013398_CR68","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature10525","volume":"478","author":"B Beck","year":"2011","unstructured":"Beck B, Driessens G, Goossens S, Youssef KK, Kuchnio A, Caauwe A et al. A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours. Nature 2011; 478: 399\u2013403.","journal-title":"Nature"},{"key":"BFonc2013398_CR69","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1126\/science.1224676","volume":"337","author":"AG Schepers","year":"2012","unstructured":"Schepers AG, Snippert HJ, Stange DE, van den Born M, van Es JH, van de Wetering M et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 2012; 337: 730\u2013735.","journal-title":"Science"},{"key":"BFonc2013398_CR70","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.stem.2008.02.009","volume":"2","author":"DJ Wong","year":"2008","unstructured":"Wong DJ, Liu H, Ridky TW, Cassarino D, Segal E, Chang HY . Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2008; 2: 333\u2013344.","journal-title":"Cell Stem Cell"},{"key":"BFonc2013398_CR71","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.stem.2011.02.020","volume":"8","author":"A Merlos-Suarez","year":"2011","unstructured":"Merlos-Suarez A, Barriga FM, Jung P, Iglesias M, Cespedes MV, Rossell D et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 2011; 8: 511\u2013524.","journal-title":"Cell Stem Cell"},{"key":"BFonc2013398_CR72","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/sj.cdd.4401872","volume":"13","author":"A Eramo","year":"2006","unstructured":"Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, Sette G et al. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 2006; 13: 1238\u20131241.","journal-title":"Cell Death Differ"},{"key":"BFonc2013398_CR73","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.stem.2007.08.001","volume":"1","author":"M Todaro","year":"2007","unstructured":"Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007; 1: 389\u2013402.","journal-title":"Cell Stem Cell"},{"key":"BFonc2013398_CR74","doi-asserted-by":"publisher","first-page":"e2428","DOI":"10.1371\/journal.pone.0002428","volume":"3","author":"SJ Dylla","year":"2008","unstructured":"Dylla SJ, Beviglia L, Park IK, Chartier C, Raval J, Ngan L et al. Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS One 2008; 3: e2428.","journal-title":"PLoS One"},{"key":"BFonc2013398_CR75","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/sj.onc.1210811","volume":"27","author":"S Ma","year":"2008","unstructured":"Ma S, Lee TK, Zheng BJ, Chan KW, Guan XY . CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt\/PKB survival pathway. Oncogene 2008; 27: 1749\u20131758.","journal-title":"Oncogene"},{"key":"BFonc2013398_CR76","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1158\/0008-5472.CAN-08-2023","volume":"69","author":"NA Dallas","year":"2009","unstructured":"Dallas NA, Xia L, Fan F, Gray MJ, Gaur P, van Buren G et al. Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res 2009; 69: 1951\u20131957.","journal-title":"Cancer Res"},{"key":"BFonc2013398_CR77","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11287","volume":"488","author":"J Chen","year":"2012","unstructured":"Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012; 488: 522\u2013526.","journal-title":"Nature"},{"key":"BFonc2013398_CR78","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.molonc.2012.10.006","volume":"6","author":"P Munoz","year":"2012","unstructured":"Munoz P, Iliou MS, Esteller M . Epigenetic alterations involved in cancer stem cell reprogramming. Mol Oncol 2012; 6: 620\u2013636.","journal-title":"Mol Oncol"},{"key":"BFonc2013398_CR79","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fgene.2012.00191","volume":"3","author":"Z Yu","year":"2012","unstructured":"Yu Z, Li Y, Fan H, Liu Z, Pestell RG . MiRNAs regulate stem cell self-renewal and differentiation. Front Genet 2012; 3: 191.","journal-title":"Front Genet"},{"key":"BFonc2013398_CR80","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.ejca.2011.01.006","volume":"47","author":"C Faber","year":"2011","unstructured":"Faber C, Horst D, Hlubek F, Kirchner T . Overexpression of Dicer predicts poor survival in colorectal cancer. Eur J Cancer 2011; 47: 1414\u20131419.","journal-title":"Eur J Cancer"},{"key":"BFonc2013398_CR81","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","volume":"68","author":"KS Hoek","year":"2008","unstructured":"Hoek KS, Eichhoff OM, Schlegel NC, Dobbeling U, Kobert N, Schaerer L et al. In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res 2008; 68: 650\u2013656.","journal-title":"Cancer Res"},{"key":"BFonc2013398_CR82","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.4161\/cc.20095","volume":"11","author":"S Ghislin","year":"2012","unstructured":"Ghislin S, Deshayes F, Middendorp S, Boggetto N, Alcaide-Loridan C . PHF19 and Akt control the switch between proliferative and invasive states in melanoma. Cell Cycle 2012; 11: 1634\u20131645.","journal-title":"Cell Cycle"},{"key":"BFonc2013398_CR83","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1038\/sj.onc.1207610","volume":"23","author":"M Munz","year":"2004","unstructured":"Munz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O . The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 2004; 23: 5748\u20135758.","journal-title":"Oncogene"},{"key":"BFonc2013398_CR84","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ncb1824","volume":"11","author":"D Maetzel","year":"2009","unstructured":"Maetzel D, Denzel S, Mack B, Canis M, Went P, Benk M et al. Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol 2009; 11: 162\u2013171.","journal-title":"Nat Cell Biol"},{"key":"BFonc2013398_CR85","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/modpathol.3800733","volume":"20","author":"MJ Gosens","year":"2007","unstructured":"Gosens MJ, van Kempen LC, van de Velde CJ, van Krieken JH, Nagtegaal ID . Loss of membranous Ep-CAM in budding colorectal carcinoma cells. Mod Pathol 2007; 20: 221\u2013232.","journal-title":"Mod Pathol"},{"key":"BFonc2013398_CR86","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/1471-2407-12-178","volume":"12","author":"TM Gorges","year":"2012","unstructured":"Gorges TM, Tinhofer I, Drosch M, Rose L, Zollner TM, Krahn T et al. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. BMC Cancer 2012; 12: 178.","journal-title":"BMC Cancer"},{"key":"BFonc2013398_CR87","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1038\/emboj.2011.211","volume":"30","author":"YJ Su","year":"2011","unstructured":"Su YJ, Lai HM, Chang YW, Chen GY, Lee JL . Direct reprogramming of stem cell properties in colon cancer cells by CD44. Embo J 2011; 30: 3186\u20133199.","journal-title":"Embo J"},{"key":"BFonc2013398_CR88","first-page":"211","volume":"41","author":"SH Cho","year":"2012","unstructured":"Cho SH, Park YS, Kim HJ, Kin CH, Lim SW, Huh JW et al. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion. Int J Oncol 2012; 41: 211\u2013218.","journal-title":"Int J Oncol"},{"key":"BFonc2013398_CR89","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.4161\/epi.6.11.18021","volume":"6","author":"MS Iliou","year":"2011","unstructured":"Iliou MS, Lujambio A, Portela A, Brustle O, Koch P, Andersson-Vincent PH et al. Bivalent histone modifications in stem cells poise miRNA loci for CpG island hypermethylation in human cancer. Epigenetics 2011; 6: 1344\u20131353.","journal-title":"Epigenetics"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/onc2013398.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/onc2013398","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/onc2013398.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:57:33Z","timestamp":1684472253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2013398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,7]]},"references-count":89,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["BFonc2013398"],"URL":"https:\/\/doi.org\/10.1038\/onc.2013.398","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,7]]}}}